Todd C. Davis, Chief Executive Officer at LIGAND PHARMACEUTICALS INC (LGND), bought 2,500 shares at $97.39 ($243K) on 2024-08-08, disclosed to the SEC on 2024-08-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| LGND | BUY | 2023-09-25 | $238K | — | Filing → |
| LGND | SELL | 2021-02-12 | $2.2M | — | Filing → |
| BDSI | SELL | 2020-08-20 | $250K | — | Filing → |